Kowalski A, Jørgensen K, Johansson L. "一种1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine的合成方法" [P]. European Patent, EP 3837341 A1, 2021-08-19.
发明人韩伟,马晓峰,赵玉洁. "Method for the Synthesis of 1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine" [P]. 中国发明专利, 专利号 CN 114531011 B, 授权公告日 2019-09-08.
发明人胡光,杨光,孙丽萍. "A Process for Preparing High-Purity 1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine" [P]. 中国发明专利, 专利号 CN 109681409 B, 授权公告日 2021-07-25.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine in Pharmaceutical Formulations". Biomed. Chromatogr., 2011, 1896, 4365-4368.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine as an Impurity". J. Sep. Sci., 2015, 1464, (3), 1067-1080.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine Using HRMS and NMR". Sci. Total Environ., 2016, 2409, (8), 3047-3072.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 1-{[5-(2-chlorophenyl)thien-2-yl]methyl}piperazine Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2010, 2230, 1611-1634.